Omeros, a US-based biopharmaceutical for disorders of the central nervous system, has made Patrick Gray, its scientific fellow after five years as chief scientific officer of Accelerator Corporation, a corporate venturing-backed investor and incubator.
The Accelerator is affiliated with biotech firm Amgen‘s Ventures unit, venture capital firms Arch Venture Partners and OVP Ventures Partners and the Institute for Systems Biology.
Previously, Gray was chief executive of Nura, a privately held biotechnology company acquired by Omeros in 2006.